Tapewire

NYSE · USD

ENOV

Enovis CORP

Export transactions ↓
Tapewire entity
4797
SEC CIK
0001420800
Parsed reports
593

Last 12 months

Inside the activity.

18 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202504
Jan 202600
Feb 202610
Mar 202670
Apr 202600
May 202600
Jun 202650
Jul 202600
Aug 202600
Sep 202640
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 21, 2021 Filed Jun 23, 2021 23:00 UTC
Trerotola Matthew L.Director · President & CEO
SaleCommon stock, par value $.001 75,000 $44.41 $3,330,450.00
Disclosure

SEC source: 0001209191-21-042837 · doc4.xml · nonDerivative · entry 2

Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,708

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.81 to $44.69, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

Read SEC document
June 21, 2021 Filed Jun 23, 2021 23:00 UTC
Trerotola Matthew L.Director · President & CEO
Exercise / conversionCommon stock, par value $.001 75,000 $23.74 $1,780,500.00
Disclosure

SEC source: 0001209191-21-042837 · doc4.xml · nonDerivative · entry 1

Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380,708

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 14, 2021 Filed Jun 16, 2021 01:00 UTC
Hix Christopher MEVP, Chief Financial Officer
Exercise / conversionEmployee stock option (right to buy) · Derivative 90,000 $0.00 Strike: $26.56 $0.00
Disclosure

SEC source: 0001209191-21-040792 · doc4.xml · derivative · entry 4

Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,611

Underlying: Common stock, par value $.001 · 90,000 shares

Expires 2023-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests in three equal annual installments on the first, second, and third anniversaries of July 1, 2016, the grant date and Mr. Hix's first day of employment with Colfax.

Read SEC document
June 14, 2021 Filed Jun 16, 2021 01:00 UTC
Hix Christopher MEVP, Chief Financial Officer
SaleCommon stock, par value $.001 100 $46.64 $4,664.00
Disclosure

SEC source: 0001209191-21-040792 · doc4.xml · nonDerivative · entry 3

Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,800

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

Read SEC document
June 14, 2021 Filed Jun 16, 2021 01:00 UTC
Hix Christopher MEVP, Chief Financial Officer
SaleCommon stock, par value $.001 89,900 $45.89 $4,125,421.10
Disclosure

SEC source: 0001209191-21-040792 · doc4.xml · nonDerivative · entry 2

Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,900

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.60 to $46.55, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

Read SEC document
June 14, 2021 Filed Jun 16, 2021 01:00 UTC
Hix Christopher MEVP, Chief Financial Officer
Exercise / conversionCommon stock, par value $.001 90,000 $26.56 $2,390,400.00
Disclosure

SEC source: 0001209191-21-040792 · doc4.xml · nonDerivative · entry 1

Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 14, 2021 Filed May 18, 2021 00:00 UTC
Trerotola Matthew L.Director · President & CEO
Exercise / conversionEmployee stock option (right to buy) · Derivative 200,000 $0.00 Strike: $23.74 $0.00
Disclosure

SEC source: 0001209191-21-033314 · doc4.xml · derivative · entry 3

Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 359,563

Underlying: Common stock, par value $.001 · 200,000 shares

Expires 2023-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 1/4/2016.

Read SEC document
May 14, 2021 Filed May 18, 2021 00:00 UTC
Trerotola Matthew L.Director · President & CEO
SaleCommon stock, par value $.001 200,000 $43.14 $8,628,400.00
Disclosure

SEC source: 0001209191-21-033314 · doc4.xml · nonDerivative · entry 2

Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,708

F1 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.89 to $43.18, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

Read SEC document
May 14, 2021 Filed May 18, 2021 00:00 UTC
Trerotola Matthew L.Director · President & CEO
Exercise / conversionCommon stock, par value $.001 200,000 $23.74 $4,748,000.00
Disclosure

SEC source: 0001209191-21-033314 · doc4.xml · nonDerivative · entry 1

Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 505,708

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2021 Filed May 14, 2021 23:00 UTC GrantCommon stock, par value $.001 3,294 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032906 · doc4.xml · nonDerivative · entry 1

GAYNER THOMAS SINNICKSON · CIK 0001159015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,587

Read SEC document
May 12, 2021 Filed May 14, 2021 23:00 UTC GrantCommon stock, par value $.001 3,294 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032912 · doc4.xml · nonDerivative · entry 1

Teirlinck Didier P · CIK 0001437676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,055

Read SEC document
May 12, 2021 Filed May 14, 2021 23:01 UTC GrantCommon stock, par value $.001 3,294 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032911 · doc4.xml · nonDerivative · entry 1

Vinnakota Rajiv · CIK 0001431876 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,182

Read SEC document
May 12, 2021 Filed May 14, 2021 23:01 UTC
Kelly LiamDirector
GrantCommon stock, par value $.001 3,294 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032910 · doc4.xml · nonDerivative · entry 1

Kelly Liam · CIK 0001552476 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,918

Read SEC document
May 12, 2021 Filed May 14, 2021 23:00 UTC GrantCommon stock, par value $.001 3,294 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032909 · doc4.xml · nonDerivative · entry 1

ALLENDER PATRICK W · CIK 0001205268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,078

Read SEC document
May 12, 2021 Filed May 14, 2021 23:00 UTC GrantCommon stock, par value $.001 3,294 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032908 · doc4.xml · nonDerivative · entry 1

Jordan Rhonda L · CIK 0001359770 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,145

Read SEC document
May 12, 2021 Filed May 14, 2021 23:00 UTC GrantCommon stock, par value $.001 3,294 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032913 · doc4.xml · nonDerivative · entry 1

PERFALL A CLAYTON · CIK 0001262173 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,676

Read SEC document
May 12, 2021 Filed May 14, 2021 23:00 UTC
Okala PhilipDirector
GrantCommon stock, par value $.001 3,294 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032907 · doc4.xml · nonDerivative · entry 1

Okala Philip · CIK 0001843147 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,651

Read SEC document
May 12, 2021 Filed May 14, 2021 23:00 UTC GrantCommon stock, par value $.001 3,294 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032905 · doc4.xml · nonDerivative · entry 1

Wienbar Sharon L · CIK 0001393556 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,783

Read SEC document
May 03, 2021 Filed May 5, 2021 00:00 UTC
Lang Patricia ASVP, Chief HR Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 24,677 $0.00 Strike: $26.88 $0.00
Disclosure

SEC source: 0001209191-21-030125 · doc4.xml · derivative · entry 3

Lang Patricia A · CIK 0001739135 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,339

Underlying: Common stock, par value $.001 · 24,677 shares

Expires 2026-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on February 25, 2020.

Read SEC document
May 03, 2021 Filed May 5, 2021 00:00 UTC
Lang Patricia ASVP, Chief HR Officer
SaleCommon stock, par value $.001 24,677 $43.94 $1,084,307.38
Disclosure

SEC source: 0001209191-21-030125 · doc4.xml · nonDerivative · entry 2

Lang Patricia A · CIK 0001739135 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,541

F1 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.90 to $44.05, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

Read SEC document
May 03, 2021 Filed May 5, 2021 00:00 UTC
Lang Patricia ASVP, Chief HR Officer
Exercise / conversionCommon stock, par value $.001 24,677 $26.88 $663,317.76
Disclosure

SEC source: 0001209191-21-030125 · doc4.xml · nonDerivative · entry 1

Lang Patricia A · CIK 0001739135 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,218

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 31, 2021 Filed Apr 7, 2021 01:00 UTC GrantCommon stock, par value $.001 486 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-025771 · doc4.xml · nonDerivative · entry 1

GAYNER THOMAS SINNICKSON · CIK 0001159015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,293

Read SEC document
March 31, 2021 Filed Apr 7, 2021 01:01 UTC GrantCommon stock, par value $.001 486 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-025773 · doc4.xml · nonDerivative · entry 1

Teirlinck Didier P · CIK 0001437676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,761

Read SEC document
March 31, 2021 Filed Apr 7, 2021 01:01 UTC GrantCommon stock, par value $.001 486 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-025774 · doc4.xml · nonDerivative · entry 1

Wienbar Sharon L · CIK 0001393556 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,489

Read SEC document
March 31, 2021 Filed Apr 7, 2021 01:00 UTC GrantCommon stock, par value $.001 600 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-025772 · doc4.xml · nonDerivative · entry 1

PERFALL A CLAYTON · CIK 0001262173 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,382

Read SEC document
March 31, 2021 Filed Apr 7, 2021 01:00 UTC GrantCommon stock, par value $.001 571 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-025770 · doc4.xml · nonDerivative · entry 1

ALLENDER PATRICK W · CIK 0001205268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,784

Read SEC document
March 19, 2021 Filed Jan 18, 2022 21:30 UTC GiftCommon Stock, par value $.001 27,904 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-002124 · doc5.xml · nonDerivative · entry 1

RALES MITCHELL P · CIK 0001015014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,142,297

Read SEC document
March 10, 2021 Filed Mar 12, 2021 02:00 UTC
Kambeyanda ShyamESAB President and EVP, Colfax
SaleCommon stock, par value $.001 8,544 $46.74 $399,346.56
Disclosure

SEC source: 0001209191-21-020005 · doc4.xml · nonDerivative · entry 4

Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,545

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs.

Read SEC document
March 10, 2021 Filed Mar 12, 2021 02:00 UTC
Kambeyanda ShyamESAB President and EVP, Colfax
SaleCommon stock, par value $.001 3,353 $46.74 $156,719.22
Disclosure

SEC source: 0001209191-21-020005 · doc4.xml · nonDerivative · entry 3

Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,089

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs.

Read SEC document
March 10, 2021 Filed Mar 12, 2021 02:00 UTC
Hix Christopher MEVP, Chief Financial Officer
SaleCommon stock, par value $.001 5,130 $46.74 $239,776.20
Disclosure

SEC source: 0001209191-21-020007 · doc4.xml · nonDerivative · entry 4

Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,800

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs.

Read SEC document
March 10, 2021 Filed Mar 12, 2021 02:00 UTC
Hix Christopher MEVP, Chief Financial Officer
SaleCommon stock, par value $.001 13,076 $46.74 $611,172.24
Disclosure

SEC source: 0001209191-21-020007 · doc4.xml · nonDerivative · entry 3

Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,930

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs.

Read SEC document
March 10, 2021 Filed Mar 12, 2021 02:00 UTC
PRYOR DANIEL AEVP, Strategy & Business Dev.
SaleCommon stock, par value $.001 20,401 $47.86 $976,391.86
Disclosure

SEC source: 0001209191-21-020006 · doc4.xml · nonDerivative · entry 6

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,257

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs.

F6 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.53 to $48.20, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (6) to this Form 4.

Read SEC document
March 10, 2021 Filed Mar 12, 2021 02:00 UTC
PRYOR DANIEL AEVP, Strategy & Business Dev.
SaleCommon stock, par value $.001 5,500 $47.27 $259,985.00
Disclosure

SEC source: 0001209191-21-020006 · doc4.xml · nonDerivative · entry 5

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,658

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs.

F5 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.53 to $47.52, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (5) to this Form 4.

Read SEC document
March 10, 2021 Filed Mar 12, 2021 02:00 UTC
PRYOR DANIEL AEVP, Strategy & Business Dev.
SaleCommon stock, par value $.001 6,157 $47.92 $295,043.44
Disclosure

SEC source: 0001209191-21-020006 · doc4.xml · nonDerivative · entry 4

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,158

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs.

F4 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.65 to $48.18, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (4) to this Form 4.

Read SEC document
March 10, 2021 Filed Mar 12, 2021 02:00 UTC
PRYOR DANIEL AEVP, Strategy & Business Dev.
SaleCommon stock, par value $.001 4,004 $47.42 $189,869.68
Disclosure

SEC source: 0001209191-21-020006 · doc4.xml · nonDerivative · entry 3

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,315

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs.

F3 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.65 to $47.64, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (3) to this Form 4.

Read SEC document
March 09, 2021 Filed Mar 12, 2021 02:00 UTC
Kambeyanda ShyamESAB President and EVP, Colfax
GrantCommon stock, par value $.001 17,690 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-020005 · doc4.xml · nonDerivative · entry 2

Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,442

F1 · kind: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

F1 · shares: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

Read SEC document
March 09, 2021 Filed Mar 12, 2021 02:00 UTC
Kambeyanda ShyamESAB President and EVP, Colfax
GrantCommon stock, par value $.001 6,941 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-020005 · doc4.xml · nonDerivative · entry 1

Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,752

F1 · kind: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

F1 · shares: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

Read SEC document
March 09, 2021 Filed Mar 12, 2021 02:00 UTC
Hix Christopher MEVP, Chief Financial Officer
GrantCommon stock, par value $.001 29,484 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-020007 · doc4.xml · nonDerivative · entry 2

Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,006

F1 · kind: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

F1 · shares: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

Read SEC document
March 09, 2021 Filed Mar 12, 2021 02:00 UTC
Hix Christopher MEVP, Chief Financial Officer
GrantCommon stock, par value $.001 11,567 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-020007 · doc4.xml · nonDerivative · entry 1

Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,522

F1 · kind: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

F1 · shares: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

Read SEC document
March 09, 2021 Filed Mar 12, 2021 02:00 UTC
PRYOR DANIEL AEVP, Strategy & Business Dev.
GrantCommon stock, par value $.001 55,284 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-020006 · doc4.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,319

F1 · kind: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

F1 · shares: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

Read SEC document
March 09, 2021 Filed Mar 12, 2021 02:00 UTC
PRYOR DANIEL AEVP, Strategy & Business Dev.
GrantCommon stock, par value $.001 21,689 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-020006 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,035

F1 · kind: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

F1 · shares: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.

Read SEC document
March 05, 2021 Filed Mar 10, 2021 02:00 UTC
Kambeyanda ShyamESAB President and EVP, Colfax
GrantCommon stock, par value $.001 17,422 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-019307 · doc4.xml · nonDerivative · entry 1

Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,811

F1 · kind: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 05, 2021 Filed Mar 10, 2021 02:00 UTC
Tandy Bradley JSVP, General Counsel
GrantCommon stock, par value $.001 9,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-019311 · doc4.xml · nonDerivative · entry 1

Tandy Bradley J · CIK 0001358283 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,911

F1 · kind: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 05, 2021 Filed Mar 10, 2021 02:00 UTC
Trerotola Matthew L.Director · President & CEO
GrantCommon stock, par value $.001 72,009 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-019312 · doc4.xml · nonDerivative · entry 1

Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,708

F1 · kind: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 05, 2021 Filed Mar 10, 2021 02:00 UTC
PRYOR DANIEL AEVP, Strategy & Business Dev.
GrantCommon stock, par value $.001 21,487 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-019310 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,346

F1 · kind: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 05, 2021 Filed Mar 10, 2021 02:00 UTC
Lang Patricia ASVP, Chief HR Officer
GrantCommon stock, par value $.001 9,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-019309 · doc4.xml · nonDerivative · entry 1

Lang Patricia A · CIK 0001739135 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,541

F1 · kind: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 05, 2021 Filed Mar 10, 2021 02:00 UTC
Shirley BradyEVP, Colfax, Pres. & CEO, DJO
GrantCommon stock, par value $.001 27,875 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-019308 · doc4.xml · nonDerivative · entry 1

Shirley Brady · CIK 0001768498 · EVP, Colfax, Pres. & CEO, DJO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,209

F1 · kind: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 02:01 UTC
Tandy Bradley JSVP, General Counsel
SaleCommon stock, par value $.001 3,536 $44.99 $159,084.64
Disclosure

SEC source: 0001209191-21-015507 · doc4.xml · nonDerivative · entry 1

Tandy Bradley J · CIK 0001358283 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,619

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

Read SEC document
February 25, 2021 Filed Feb 27, 2021 02:01 UTC
Kambeyanda ShyamESAB President and EVP, Colfax
SaleCommon stock, par value $.001 1,850 $46.01 $85,118.50
Disclosure

SEC source: 0001209191-21-015062 · doc4.xml · nonDerivative · entry 1

Kambeyanda Shyam · CIK 0001673243 · ESAB President and EVP, Colfax

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,389

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

Read SEC document
February 25, 2021 Filed Feb 27, 2021 02:01 UTC
PRYOR DANIEL AEVP, Strategy & Business Dev.
SaleCommon stock, par value $.001 1,961 $46.01 $90,225.61
Disclosure

SEC source: 0001209191-21-015063 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,859

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.